NCT03338062

A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy

A Pilot Study to Assess Theragnostically Planned Liver Radiation With Functional DVH Analysis to Optimize Individualized Radiation Therapy

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Indiana University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare radiation treatment plans that are designed for patients with liver cancer. One treatment plan will be created using routine procedures and scans normally performed for radiation treatment planning. The other treatment plan will be created using routine procedures with the addition of two imaging scans; a HIDA (Hepatobiliary Iminodiacetic Acid) scan and an MRI (Magnetic Resonance Imaging) scan. This study will evaluate if adding these imaging scans to treatment planning can reduce the amount of radiation to healthy liver tissue during treatment.

Conditions

• Liver Cancer
• Hepatocellular Carcinoma
• Cholangiocarcinoma

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Hepatobiliary Iminodiacetic Acid (HIDA) scan	HIDA scan was used as the planning scan for SBRT.

Timeline

• Start date: 2017-06-13
• Primary completion: 2019-09-02
• Completion: 2019-09-02
• First posted: 2017-11-09
• Last updated: 2021-02-26
• Results posted: 2021-02-26

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study